Page last updated: 2024-09-02

afdx 116 and Carcinoma, Anaplastic

afdx 116 has been researched along with Carcinoma, Anaplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garland, CJ; Hillier, K; Kerr, PM; Wallis, RM1
Kopp, R; Lambrecht, G; Moser, U; Mutschler, E; Pfeiffer, A; Tacke, R1

Other Studies

2 other study(ies) available for afdx 116 and Carcinoma, Anaplastic

ArticleYear
Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.
    British journal of pharmacology, 1995, Volume: 115, Issue:8

    Topics: Alkaloids; Atropine; Carbachol; Carcinoma; Colon; Colonic Neoplasms; Dose-Response Relationship, Drug; Furans; Humans; In Vitro Techniques; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperidines; Pirenzepine

1995
Human HT-29 colon carcinoma cells contain muscarinic M3 receptors coupled to phosphoinositide metabolism.
    European journal of pharmacology, 1989, Oct-17, Volume: 172, Issue:4-5

    Topics: Carbachol; Carcinoma; Colonic Neoplasms; Gastric Mucosa; Humans; Inositol Phosphates; Phosphatidylinositols; Pirenzepine; Receptors, Muscarinic; Tumor Cells, Cultured

1989